Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 ASO Author Reflections: Avoiding an Axillary Lymph Node Dissection: The Benefit of Neoadjuvant Chemotherapy for Occult Primary Breast Cancer.

× No keyword cloud information.

4 in total

Review 1. The diagnostic performance of sentinel lymph node biopsy in pathologically confirmed node positive breast cancer patients after neoadjuvant systemic therapy: A systematic review and meta-analysis.

Authors: T J A van Nijnatten; R J Schipper; M B I Lobbes; P J Nelemans; R G H Beets-Tan; M L Smidt
Journal: Eur J Surg Oncol Date: 2015-08-22 Impact factor: 4.424

2. How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study.

Authors: Anita Mamtani; Andrea V Barrio; Tari A King; Kimberly J Van Zee; George Plitas; Melissa Pilewskie; Mahmoud El-Tamer; Mary L Gemignani; Alexandra S Heerdt; Lisa M Sclafani; Virgilio Sacchini; Hiram S Cody; Sujata Patil; Monica Morrow
Journal: Ann Surg Oncol Date: 2016-05-09 Impact factor: 5.344

3. Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial.

Authors: Judy C Boughey; Linda M McCall; Karla V Ballman; Elizabeth A Mittendorf; Gretchen M Ahrendt; Lee G Wilke; Bret Taback; A Marilyn Leitch; Teresa Flippo-Morton; Kelly K Hunt
Journal: Ann Surg Date: 2014-10 Impact factor: 12.969

4. Axillary Downstaging in Occult Primary Breast Cancer After Neoadjuvant Chemotherapy.

Authors: Astrid Botty Van den Bruele; Jessica Lavery; George Plitas; Melissa L Pilewskie
Journal: Ann Surg Oncol Date: 2020-08-19 Impact factor: 5.344

4 in total